Inventor · disambiguated record
Robert Roscigno
Also filed as: ROSCIGNO ROBERT · ROSCIGNO ROBERT F · ROSCIGNO ROBERT FRANK
14 granted patents·12 pending applications·267 citations·filing 1998–2025
93Inventor score
Top patents by PatentIndex Score
26 records- 0196US10716793B2Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2020·Granted Jul 21, 2020·11 cites·8 claims
- 0294US10898494B2Dry powder treprostinil for the treatment of pulmonary hypertensionLIQUIDIA TECH INC·Filed 2017·Granted Jan 26, 2021·7 cites·19 claims
- 0394US9358240B2Treprostinil administration by inhalationOLSCHEWSKI HORST·Filed 2009·Granted Jun 7, 2016·33 cites·9 claims
- 0494US9339507B2Treprostinil administration by inhalationOLSCHEWSKI HORST·Filed 2012·Granted May 17, 2016·38 cites·9 claims
- 0593US10376525B2Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2016·Granted Aug 13, 2019·13 cites·4 claims
- 0690US6054486AUse of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular diseaseUNITED THERAPEUTICS CORP·Filed 1998·Granted Apr 25, 2000·121 cites·17 claims
- 0788US8765813B2Use of treprostinil to treat and prevent ischemic lesionsWADE MICHAEL·Filed 2004·Granted Jul 1, 2014·42 cites·41 claims
- 0886US2025332175A1Dry Powder Treprostinil for the Treatment of Pulmonary HypertensionLIQUIDIA TECH INC·Filed 2025·Application pending·0 cites
- 0984US12390475B2Dry powder treprostinil for the treatment of pulmonary hypertensionLIQUIDIA TECH INC·Filed 2023·Granted Aug 19, 2025·0 cites·20 claims
- 1083US2023062605A1Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1181US11660304B2Dry powder treprostinil for the treatment of pulmonary hypertensionLIQUIDIA TECH INC·Filed 2022·Granted May 30, 2023·0 cites·19 claims
- 1281US2022323459A1Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1381US2022218720A1Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1479US11357782B2Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2021·Granted Jun 14, 2022·0 cites·11 claims
- 1577US11744835B2Dry powder treprostinil for the treatment of pulmonary hypertensionLIQUIDIA TECH INC·Filed 2021·Granted Sep 5, 2023·0 cites·21 claims
- 1677US11744836B2Dry powder treprostinil for the treatment of pulmonary hypertensionLIQUIDIA TECH INC·Filed 2021·Granted Sep 5, 2023·0 cites·21 claims
- 1777US11154210B2Method of determining vasoreactivity using inhaled nitric oxideVero Biotech LLC·Filed 2013·Granted Oct 26, 2021·2 cites·4 claims
- 1874US11712442B2Dry powder treprostinil for the treatment of pulmonary hypertensionLIQUIDIA TECH INC·Filed 2020·Granted Aug 1, 2023·0 cites·18 claims
- 1970US2019365778A1Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 2063US2008200449A1Treprostinil administration using a metered dose inhalerUNITED THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 2161US2008280986A1Treprostinil treatment for interstitial lung disease and asthmaUNITED THERAPEUTICS CORP·Filed 2008·Application pending·0 cites
- 2258US2014018431A1Treprostinil treatment for interstitial lung disease and asthmaUNITED THERAPEUTICS CORP·Filed 2013·Application pending·0 cites
- 2356US2013096200A1Treprostinil treatment for interstitial lung disease and asthmaUNITED THERAPEUTICS CORP·Filed 2012·Application pending·0 cites
- 2454US2012129941A1Treprostinil treatment for interstitial lung disease and asthmaWADE MICHAEL·Filed 2012·Application pending·0 cites
- 2547US2009036465A1Combination therapy for pulmonary arterial hypertensionUNITED THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 2639US2012093948A1Nitric Oxide TreatmentsFINE DAVID H·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Roscigno files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →